ArticleOncotarget2017

Circulating tumor DNA profiling by next generation sequencing reveals heterogeneity of crizotinib resistance mechanisms in a gastric cancer patient with MET amplification.

Juan Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.